News

The cardiopatch study was conducted by researchers from the Faculty of Medicine of the Geneva University in collaboration with Ecole Polytechnique Federale de Lausanne (EPFL). Using a protein

According to the study, patients with more severe symptoms achieved a greater improvement following treatment with the ToleroMune T-cell vaccine than those on placebo (p=0.05). Therandomized, double-blind studywas

The Data from INSPIRE 2 HIV study showed that CYT107 administration can expand CD4 and CD8 T-cells while increasing the expression of gut homing molecules that may result

The Revitas revenue management solution allows pharmaceutical manufacturers to minimise the payment of erroneous claims for rebate and administrative fee payments by validating rebate claims for individual prescriptions.

Chronix has opened the laboratory in association with the First Bank & Trust of Brookings, South Dakota and the Area Development Corporation of Brookings, South Dakota. The Brookings

Notice of allowance has been granted to member patents of this family in the US, Japan, India, China, Korea, Mexico, Israel and Australia. BL-1020 is a novel, first

Lodotra is a proprietary, programmed-release formulation of low-dose prednisone and has received regulatory approval in Europe for the treatment of moderate to severe active rheumatoid arthritis (RA) when

The acquisition of Xcellerex will allow GE Healthcare to expand its offering of products and services for the manufacture of biopharmaceuticals such as recombinant proteins, antibodies and vaccines.

Mersana Therapeutics has signed a collaboration agreement with Endo Pharmaceuticals to develop next-generation antibody-drug conjugates (ADCs). Under the deal, Endo will pay an upfront fee to Mersana for